Preconference

Pharmacometrics Phisticuffs 2* – Is Clinical Pharmacology an enabler or a barrier for Pharmacometrics?

Saturday, October 18, 2025

11:15 AM - 11:45 AM MDT

Location: Willow Lake 3 - 5

Chair(s)

Stacey Tannenbaum, PhD, FISoP (she/her/hers)

Consultant and Coach to the MIDD Community
SJTPharm LLC
Northbrook, Illinois, United States

Nieves Velez de Mendizabal, PhD (she/her/hers)

Executive Director
Eli Lilly and Company
Indianapolis, Indiana, United States
Jackson Burton, PhD

Scientific Director, Clinical Pharmacology and Pharmacometrics
Biogen, Arizona, United States

Disclosure(s):

Stacey Tannenbaum, PhD, FISoP: No financial relationships to disclose

Nieves Velez de Mendizabal, PhD: No relevant disclosure to display

Jackson Burton, PhD: No relevant disclosure to display